News

  • Banner_OwnershipStructures

Xplico article for Biotech & Money / LSX

October, 2018|0 Comments

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Finn Nikolajsen, gives his point of view on the challenges of the ownership structures that the biotech […]

  • Gazelle_Featured

Xplico named “a 2018 Gazelle Company” (a growth company) for the third year in a row by the leading Danish business newspaper Børsen.

October, 2018|0 Comments

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2018 Gazelle Company for the 3rd year in a row. Børsen analyses every year all the Danish companies to identify growth […]

  • Skærmbillede 2018-08-24 kl. 16.04.22

Xplico article for Biotech & Money / LSX

August, 2018|0 Comments

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, gives his point of view on the challenges that the Nordic life science companies face.

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team

August, 2018|0 Comments

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team as Executive Assistant and will be working closely together with the partners Uffe Boesen and Finn Nikolajsen.
Sisse holds a Master’s Degree in […]

  • Boston

LSX World Congress USA in Boston, October 10-11, 2018

August, 2018|0 Comments

LSX World Congress USA in Boston, October 10-11, 2018


Please meet us at the LSX World Congress USA in Boston. LSX World Congress USA is a high-calibre, senior executive conference and partnering event providing the education, […]

  • BIO-Europe-2018

BIO-Europe 2018, Copenhagen, Denmark, November 5-7, 2018

August, 2018|0 Comments

BIO-Europe 2018, Copenhagen, Denmark, November 5-7, 2018

Please meet us at the 2018 International Partnering Conference in our hometown Copenhagen, Denmark. BIO-Europe is Europe’s largest partnering conference, serving the global biotechnology industry. The conference annually attracts […]

  • Lille

Biofit 2018, Lille, France, December 4-5, 2018

August, 2018|0 Comments

Biofit 2018, Lille, France, December 4-5, 2018

Please meet us at 2018 Biofit conference in Lille. BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of […]

  • Biotech-SanFran

Biotech Showcase 2019, San Francisco, USA, January 7–9, 2019

August, 2018|0 Comments

Biotech Showcase 2019, San Francisco, USA, January 7–9, 2019


Please meet us at the 2019 Biotech Showcase in San Francisco. The investor and networking conference for public and private biotech companies to meet with and present […]

  • Austria_Vienna

BIO-Europe Spring 2019, Vienna, Austria, March 25 – 27, 2019

August, 2018|0 Comments

BIO-Europe Spring 2019, Vienna, Austria, March 25 – 27, 2019


Please meet us at the 2019 BIO-Europe Spring Partnering Conference in Vienna, Austria. With a focus on European innovation and global collaboration, BIO-Europe Spring is the […]

  • 1

Xplico Interview with Biotech & Money / LSX

July, 2018|0 Comments

In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, explains how valuation is critical for strategic decision-making and points out to some of the […]

  • Xplico_Gazelle

Xplico named “a 2017 Gazelle Company” (a growth company) for the second year in a row by the leading Danish business newspaper Børsen.

February, 2018|0 Comments

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2017 Gazelle Company for the 2nd year in a row. Børsen analyses every year all the Danish companies to identify growth […]

Xplico is pleased to announce that Golnaz Borghei has joined our valuation team.

February, 2018|0 Comments

Golnaz has 10+ years’ experience in biotech and medtech research and industry. She holds a PhD in Analytical Biotechnology from Cambridge University followed by several years of research in physiology at Cambridge and Oxford universities […]

  • Xplico_Gazelle_2016

Xplico named “a 2016 Gazelle Company” (a growth company) by the leading Danish business newspaper Børsen.

January, 2017|0 Comments

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2016 Gazelle Company. Børsen analyses every year all the Danish companies to identify growth companies. A Gazelle company is defined by […]

Xplico is pleased to announce that Peter Abelin has joined our valuation team.

January, 2017|0 Comments

Xplico is pleased to announce that Peter Abelin has joined our valuation team.
Peter has more than 25 years’ experience from the life science industry working with equity portfolio management, financial research and pharmaceutical development […]

Xplico launches Xplico Captable – a cap table providing simulations and waterfall analysis of the various stakeholders’ investments and values in a company.

January, 2017|0 Comments

Xplico Captable is a capitalization table providing simulations and waterfall analysis of the founders’ and investors’ percentage of ownership, equity dilution, and value of equity in connection with (potential) funding rounds and exits. Xplico Captable […]

  • Bi-Pharm-America-2019

Bio International Convention, Philadelphia, USA, June 3-6, 2019

September, 2014|0 Comments

Bio International Convention, Philadelphia, USA, June 3-6, 2019

Please meet us at the BIO International Convention in Philadelphia in June 2019. The key benefits of attending the Convention are access to global biotech and pharma leaders […]